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Abstract
High glucose concentrations have been shown to activate endothelial cells and promote angiogenesis. In the 
present study, it was investigated whether high glucose concentrations could improve the vascularisation 
capacity of adipose-tissue-derived microvascular fragments (ad-MVF). Ad-MVF were isolated from the 
epididymal fat pads of donor mice and cultivated for 24 h in University of Wisconsin (UW) solution 
supplemented with vehicle or 30 mM glucose. Protein expression, morphology, viability and proliferation 
of the cultivated ad-MVF were analysed by means of proteome profiler mouse angiogenesis array, scanning 
electron microscopy and immunohistochemistry. Additional cultivated ad-MVF were seeded on to collagen-
glycosaminoglycan scaffolds to study their in vivo vascularisation capacity in the dorsal skinfold chamber 
model by intravital fluorescence microscopy, histology and immunohistochemistry. In vitro, high glucose 
exposure changed the protein expression pattern of ad-MVF with endoglin, interleukin (IL)-1β and monocyte 
chemoattractant protein (MCP)-1 as the most up-regulated pro-angiogenic factors. Moreover, high glucose 
exposure induced the formation of nanopores in the ad-MVF wall. In addition, ad-MVF contained significantly 
larger numbers of proliferating endothelial and perivascular cells while exhibiting a comparable number of 
apoptotic cells when compared to vehicle-treated controls. In vivo, scaffolds seeded with high-glucose-exposed 
ad-MVF exhibited an improved vascularisation and tissue incorporation. These findings demonstrated that 
the exposure of cultivated ad-MVF to high glucose concentrations is a promising approach to improve their 
in vivo performance as vascularisation units for tissue engineering and regenerative medicine.
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vascularisation, scaffold.
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Introduction
Adipose-tissue-derived microvascular fragments 
(ad-MVF) are arteriolar, capillary and venular 
vessel segments, which are isolated by short-term 
enzymatic digestion of fat samples (Laschke and 
Menger, 2015). Originally, these vessel segments 
have been used in physiology and angiogenesis 
research to study endothelial transport processes 
(Williams et al., 1981), interaction of endothelial 
cells with extracellular matrix compounds (Madri et 
al., 1983) or effects of cytokines and growth factors 
on microvascular network formation (Sato et al., 
1990; Sato et al., 1993). More recently, ad-MVF have 
been incorporated into different scaffold materials 
to improve the vascularisation of implanted tissue 
constructs, such as epicardial patches (Shepherd et 
al., 2007) or bone and dermal skin substitutes (Frueh 
et al., 2017a; Laschke et al., 2012).
 Ad-MVF bear several unique advantages, 
which make them attractive vascularisation units 
for tissue engineering and regenerative medicine. 
They can be isolated in large amounts quickly 
from fat samples (Frueh et al., 2017b). Due to their 
preserved vessel architecture and functionality 
after isolation, they rapidly reassemble into new 
blood-perfused microvascular networks after in 
vivo implantation (Später et al., 2018). Moreover, 
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they contain mesenchymal stem cells within their 
physiological niche, which exhibit a high capacity for 
angiogenic, neurogenic, adipogenic and osteogenic 
differentiation (McDaniel et al., 2014). In addition, ad-
MVFs can be pre-cultivated for up to 24 h prior to their 
in vivo application without losing their physiological 
vessel morphology (Laschke et al., 2019a). This offers 
the possibility of further improving their angiogenic 
activity by exposing them to different physical and 
biochemical stimuli, such as subnormothermic 
temperatures and pro-angiogenic factors (Karschnia 
et al., 2018; Laschke et al., 2019a; Laschke et al., 2019b).
 The study hypothesis was that the in vitro exposure 
of cultivated ad-MVF to high glucose concentrations 
increases their in vivo microvascular-network-
forming capacity. This assumption was based on 
the fact that hyperglycaemia in diabetic patients is 
typically associated with excessive angiogenesis in 
different organs, which, for example, causes diabetic 
retinopathy and nephropathy (Aouiss et al., 2019; 
Zent and Pozzi, 2007). In line with this finding, 
several in vitro studies have reported that high-
glucose-treated endothelial cells exhibit an increased 
proliferating, migrating and tube-forming activity 
due to the upregulation of angiogenic signalling 
pathways (Betts-Obregon et al., 2016; Fernando et al., 
2018; Qiu et al., 2018; Shi et al., 2019).
 To test the study hypothesis, ad-MVF isolated 
from epididymal fat pads of donor mice were exposed 
in vitro for 24 h to high glucose and their protein 
expression, morphology, viability and proliferation 
were analysed in comparison to vehicle-exposed 
controls. Moreover, collagen-glycosaminoglycan 
scaffolds seeded with high-glucose- and vehicle-
exposed ad-MVFs were implanted into dorsal 
skinfold chambers of recipient mice to study their in 
vivo vascularisation and incorporation.
Materials and Methods
Ethical statement
The study was approved by the local governmental 
animal protection committee (Landesamt für 
Verbraucherschutz, Abteilung C Lebensmittel- und 
Veterinärwesen, Saarbrücken, Germany; permission 
number: 29/2014). All experiments were conducted 
in accordance with the Directive 2010/63/EU and the 
NIH Guidelines for the Care and Use of Laboratory 
Animals (NIH Publication #85-23 Rev. 1985).
Animals
For the isolation of ad-MVF, male C57BL/6 wild-type 
mice and C57BL/6-TgN(ACTB-EGFP)1Osb/J mice 
(age: 6-12 months; body weight: > 30 g; Institute 
for Clinical and Experimental Surgery, Saarland 
University, Homburg/Saar, Germany) were used 
as fat donors. The latter ubiquitously express green 
fluorescent protein (GFP) (Okabe et al., 1997). Dorsal 
skinfold chambers were implanted into C57BL/6 
wild-type mice (age: 3-5 months; body weight: 22-
27 g). Animals were housed in the animal facility of 
the Institute for Clinical and Experimental Surgery 
(Saarland University, Homburg/Saar, Germany) with 
access to tap water and standard pellet food ad libitum 
(Altromin, Lage, Germany).
Isolation and cultivation of ad-MVF
Ad-MVF were isolated from the epididymal fat pads 
of donor mice (Fig. 1a-c), as described previously in 
detail (Frueh et al., 2017b). In brief, the donor animals 
were anaesthetised by intraperitoneal injection 
of ketamine (100 mg/kg body weight; Ursotamin, 
Serumwerk Bernburg AG, Bernburg, Germany) and 
xylazine (12 mg/kg body weight; Rompun, Bayer, 
Leverkusen, Germany), laparotomised and sacrificed 
by incision of the abdominal aorta. The epididymal 
fat pads were excised, mechanically minced and 
digested in collagenase NB4G (0.5 U/mL; Serva, 
Heidelberg, Germany) for 9 min while being stirred 
at 37 °C under humidified atmospheric conditions. 
Subsequently, the enzyme was neutralised with 
phosphate-buffered saline (PBS) containing 20 % 
foetal calf serum (FCS) and the suspension was 
filtered through a 500 µm mesh (pluriSelect Life 
Science, Leipzig, Germany) to remove non-digested 
fat clots. Moreover, fat supernatants were carefully 
removed. The remaining ad-MVF were finally 
enriched up to a pellet size by centrifugation for 
5 min at 120 ×g.
 The isolated ad-MVF were cultivated for 24 h 
under humidified conditions in 1 % agarose-coated 
24-well plates containing 4 °C University of Wisconsin 
(UW) solution (Belzer UW Cold Storage Solution, 
Bridge to Life Ltd., Columbia, SC, USA). These culture 
conditions have previously been proven to be suitable 
for the xeno-free cultivation of ad-MVF, as it would 
be necessary in future clinical practice (Laschke et 
al., 2019b). The UW solution was supplemented with 
30 mM glucose (high glucose; Carl Roth, Karlsruhe, 
Germany) or vehicle (control; PBS). At the end of the 
24 h cultivation period, the ad-MVF were washed in 
PBS prior to further analyses.
Protein expression of ad-MVF
The expression of 53 pro- and anti-angiogenic 
proteins was analysed in vehicle- and high-glucose-
exposed ad-MVF by means of a proteome profiler 
mouse angiogenesis array kit (R&D Systems, 
Wiesbaden, Germany), as described previously in 
detail (Laschke et al., 2018).
Scaffold preparation and seeding
Vehicle- and high-glucose-exposed ad-MVF 
were seeded on to clinically available collagen-
glycosaminoglycan scaffolds (Integra®; Integra 
GmbH, Ratingen, Germany) having a diameter of 
3 mm (Fig. 1c). A detailed description of the scaffold 
preparation and seeding procedure is given in 
Laschke et al. (2019b).
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Morphology of ad-MVF
The morphology of vehicle- and high-glucose-exposed 
ad-MVF seeded on to collagen-glycosaminoglycan 
scaffolds was analysed by means of a FEI XL-30 
ESEM FEG scanning electron microscopy device (FEI, 
Hillsboro, OR, USA). A detailed description of the 
sample preparation is given in Laschke et al. (2018).
Dorsal skinfold chamber model and intravital 
fluorescence microscopy
Vehicle- and high-glucose-exposed ad-MVF from 
GFP+ donor mice were seeded on to collagen-
glycosaminoglycan scaffolds, which were implanted 
into dorsal skinfold chambers of GFP− recipient 
mice (Fig. 1d,e) and analysed by means of intravital 
fluorescence microscopy, as described previously in 
detail (Laschke et al., 2019a). For contrast enhancement 
by intravascular staining of plasma, 100 µL 5 % 
FITC-labelled dextran 150,000 (Sigma-Aldrich) 
were injected before each microscopy analysis into 
the retrobulbary plexus of the anaesthetised mice. 
The microscopy images were analysed with the 
computer-assisted off-line analysis system CapImage 
(Zeintl, Heidelberg, Germany). The vascularisation 
of the implants was assessed in 8 regions of interest 
(ROIs). Perfused ROIs (in percentage of all ROIs) were 
defined as areas containing either newly developed 
red blood cell (RBC)-perfused microvessels or 
reperfused GFP+ ad-MVF. In addition, the functional 
microvessel density, i.e. the length of all RBC-
perfused microvessels per ROI given in cm/cm2, 
as well as the diameter (D; given in µm) and the 
centreline RBC velocity (v; given in µm/s) of 30 
randomly selected perfused microvessels within the 
implants were measured. The wall shear rate (y; given 
in s−1) of these vessels was then calculated with the 
formula: y = 8 × v/D.
Experimental protocol
For in vitro analyses, ad-MVF were isolated from 
epididymal fat pads of 32 GFP− donor mice. 
Isolated ad-MVF were divided into two equal 
parts and cultivated for 24 h in 4 °C UW solution, 
which was supplemented with vehicle or high 
Fig. 1. Isolation of ad-MVF 
and experimental model. (a) 
Epididymal fat pad of a C57BL/6 
donor mouse. Scale bar: 3.5 mm. 
(b) Brightfield microscopy of an 
ad-MVF (arrow) directly after 
enzymatic isolation from the 
epididymal fat pad. Scale bar: 
35 µm. (c) Schematic overview of the 
ad-MVF isolation and preparation 
procedure. Ad-MVF were isolated 
by enzymatic digestion of the 
epididymal fat pads of donor 
mice. After the removal of fat 
supernatants,  ad-MVF were 
enriched up to a pellet size and 
subsequently cultivated for 24 h in 
4 °C UW solution containing high 
glucose or vehicle. Thereafter, the 
ad-MVF were seeded on to collagen-
glycosaminoglycan scaffolds 
for further in vitro and in vivo 
analyses. (d) C57BL/6 mouse with 
a dorsal skinfold chamber. Scale 
bar: 12.5 mm. (e) Stereomicroscopy 
of the observation window of a 
dorsal skinfold chamber after the 
implantation of an ad-MVF-seeded 
col lagen-glycosaminoglycan 
scaffold (borders marked by broken 
line). Scale bar: 1.5 mm. 
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Table 1. Expression of angiogenesis-related proteins (percentage of vehicle) in ad-MVF as assessed 
by a proteome profiler mouse angiogenesis array. ad-MVF were cultivated for 24 h in 4 °C UW solution 
supplemented with vehicle or high glucose.
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Fig. 2. Morphology of ad-MVF. (a-d) Scanning electron microscopy of ad-MVF directly after their 
seeding on to collagen-glycosaminoglycan matrices. ad-MVF were cultivated for 24 h in 4 °C UW solution 
supplemented with (a,b) vehicle or (c,d) high glucose. Arrows = pericytes; arrowheads = nanopores. (b,d) 
Higher magnification (scale bar: 1.4 µm) of inserts in a and c (scale bar: 11 µm).
glucose. Immediately after cultivation, the protein 
expression of the ad-MVF was analysed by means 
of a proteome profiler mouse angiogenesis array kit 
(n = 2 per group). Additional ad-MVF were seeded 
on to collagen-glycosaminoglycan scaffolds to study 
their morphology by means of scanning electron 
microscopy (n = 2 per group) and their viability and 
proliferation by means of immunohistochemistry 
(n = 4 per group).
 For in vivo analyses, ad-MVF were isolated from 
the epididymal fat pads of 20 GFP+ donor mice and 
cultivated as described above. Subsequently, they 
were seeded on to collagen-glycosaminoglycan 
scaffolds, which were implanted into the dorsal 
skinfold chambers of 18 GFP− recipient mice (vehicle: 
n = 9; high glucose: n = 9). The scaffolds were analysed 
directly after implantation (day 0) and on days 3, 
6, 10 and 14 by means of intravital fluorescence 
microscopy. Thereafter, animals were sacrificed 
with an overdose of anaesthetics and the implants 
with the surrounding tissue were excised for further 
histological and immunohistochemical analyses.
Histology and immunohistochemistry
Formalin-fixed specimens of ad-MVF-seeded non-
implanted and implanted scaffolds were embedded 
in paraffin-wax and cut into 3 µm-thick sections. 
Sections were stained with haematoxylin and eosin 
(HE), sirius red and antibodies against the apoptosis 
marker cleaved caspase (Casp)-3, the proliferation 
marker Ki67, the endothelial marker CD31 and the 
fluorescence marker GFP, as described previously in 
detail (Laschke et al., 2019a). Sections were analysed 
using a BX60 microscope (Olympus, Hamburg, 
Germany).
 Collagen content of implanted ad-MVF-seeded 
scaffolds, as assessed by means of the reddish 
appearance of mature sirius-red-stained collagen 
type I fibres under polarised-light microscopy in 
relation to normal skin, was measured in 4 ROIs of 
each sample using the imaging software cellSens 
Dimension 1.11 (Olympus) (Frueh et al., 2017a). 
Additional quantitative analyses included the 
determination of the fractions of Casp-3+ and Ki67+ 
cells (given in percentage) in randomly selected 
ad-MVF, including at least 100 endothelial and 
perivascular cells per sample. Moreover, the density 
of all CD31+ microvessels (given in mm−2) and the 
fraction of CD31+/GFP+ microvessels of all CD31+ 
microvessels (given in percentage) were assessed 
in the centre and border zones of ad-MVF-seeded 
implants.
Statistical analysis
Data were tested for normal distribution and 
equal variance. In case of parametric distribution 
of the data, differences between the groups were 
analysed by unpaired Student’s t-test. In case of non-
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parametric distribution of the data, differences were 
assessed by Mann-Whitney rank sum test (SigmaPlot 
11.0; Jandel Corporation, San Rafael, CA, USA). All 
values are given as mean ± standard error of the 
mean (SEM). Statistical significance was accepted for 
a value of p < 0.05.
Results
ad-MVF protein expression
In a first set of experiments, a proteome profiler 
mouse angiogenesis array was performed to analyse 
the expression of pro- and anti-angiogenic factors in 
cultivated ad-MVF. This array revealed a difference in 
protein expression pattern between vehicle- and high-
glucose-treated ad-MVF (Table 1). In comparison 
to controls, the most increased protein levels were 
detected in high-glucose-exposed ad-MVF for the 
pro-angiogenic factors endoglin, interleukin (IL)-
1β and monocyte chemoattractant protein (MCP)-
1. In contrast, the pro-angiogenic factor matrix 
metalloproteinase (MMP)-8 and its counterpart tissue 
inhibitor of matrix metalloproteinase (TIMP)-1 were 
the most downregulated proteins (Table 1).
Morphology of ad-MVF
A d - M V F  w e r e  s e e d e d  o n  t o  c o l l a g e n -
glycosaminoglycan scaffolds directly after the 
24 h-cultivation period and analysed by means 
Fig. 3. Viability and proliferation of ad-MVF. (a-d) Fluorescence microscopy of ad-MVF directly after 
their seeding on to collagen-glycosaminoglycan matrices. ad-MVF were cultivated for 24 h in 4 °C UW 
solution supplemented with (a,c) vehicle or (b,d) high glucose. (a-d) Staining was performed with Hoechst 
33342 (blue) for the detection of cell nuclei and an antibody against CD31 (green) for the identification of 
endothelial cells in combination with an antibody against (a,b) Casp-3 (red) for the labelling of apoptotic 
cells or (c,d) against Ki67 (red) for the labelling of proliferating cells. Arrows = marker-positive endothelial 
cells; arrowheads = marker-positive perivascular cells. Scale bars: 10 µm. Percentage of (e) Casp-3+ cells 
and (f) Ki67+ cells within ad-MVF, which were cultivated for 24 h in 4 °C UW solution supplemented with 
vehicle (white bars, n = 4) or high glucose (black bars, n = 4). Mean ± SEM; * p < 0.05 vs. vehicle.
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of scanning electron microscopy to assess their 
morphology (Fig. 2a-d). Both high-glucose- and 
vehicle-exposed ad-MVF exhibited a comparable 
vessel morphology, with attached stabilising 
pericytes (Fig. 2a,c). However, higher magnifications 
revealed multiple nanopores in high-glucose-exposed 
ad-MVF, which could not be observed in vehicle-
treated controls, indicating a beginning disintegration 
of their vessel walls (Fig. 2b,d).
Viability and proliferation of ad-MVF
Immunohistochemical analyses showed a comparable 
fraction of Casp-3+ apoptotic endothelial and 
perivascular cells in vehicle- and high-glucose-
exposed ad-MVF (Fig. 3a,b,e). In contrast, high-
glucose-exposed ad-MVF exhibited a significantly 
higher number of Ki67+ proliferating endothelial 
and perivascular cells when compared to controls 
(Fig. 3c,d,f).
In vivo vascularisation capacity of ad-MVF
To assess their in vivo vascularisation capacity, 
GFP+ vehicle- and high-glucose-exposed ad-MVF 
were seeded on to collagen-glycosaminoglycan 
scaffolds, which were implanted into the dorsal 
skinfold chambers of GFP− wild-type recipient 
mice. Repetitive intravital fluorescent microscopy 
analyses of the implants revealed that ad-MVF of 
both groups were able to rapidly reassemble into 
microvascular networks (Fig. 4a-j). These networks 
also developed interconnections to the surrounding 
host microvasculature. Accordingly, there were no 
significant differences in the fraction of perfused 
ROIs between the two groups throughout the 
14 d-observation period (Fig. 4k). However, more 
detailed analyses of the newly developing networks 
showed a significantly higher functional microvessel 
density in scaffolds seeded with high-glucose-
exposed ad-MVF between day 6 and 14 when 
compared to controls (Fig. 4l). In addition, individual 
microvessels within these scaffolds presented with a 
significantly smaller diameter and higher centreline 
RBC velocity at later observation time points (Fig. 
5a-d). Accordingly, the calculated wall shear rate 
of these vessels was also significantly higher when 
compared to controls (Fig. 5e). These findings 
Fig. 4. In vivo vascularisation capacity of ad-MVF. (a-j) Intravital fluorescence microscopy (blue-light epi-
illumination with contrast enhancement by 5 % FITC-labelled dextran 150,000 injected intravenous) of ad-
MVF-seeded collagen-glycosaminoglycan scaffolds on day 0, 3, 6, 10 and 14 after implantation into the dorsal 
skinfold chamber of C57BL/6 mice. ad-MVF were cultivated for 24 h in 4 °C UW solution supplemented with 
(a-e) vehicle or (f-j) high glucose. Arrows = GFP+ ad-MVF. Scale bars: 85 µm. (k) Percentage of perfused ROIs 
and (l) functional microvessel density (cm/cm2) of ad-MVF-seeded collagen-glycosaminoglycan scaffolds 
directly (0 d) as well as 3, 6, 10 and 14 d after implantation into dorsal skinfold chambers, as assessed by 
intravital fluorescence microscopy. ad-MVF were cultivated for 24 h in 4 °C UW solution supplemented with 
vehicle (white circles, n = 9) or high glucose (black circles, n = 9). Mean ± SEM; * p < 0.05 vs. vehicle. 
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indicated an improved vascularisation as well as 
vascular maturation and remodelling of the scaffolds 
with the high-glucose-exposed ad-MVF.
 At the end of the in vivo experiments, ad-MVF-
seeded scaffolds were additionally analysed by 
means of histology and immunohistochemistry. 
HE-stained sections showed a denser granulation 
tissue within the pores and the surrounding host 
tissue of implants seeded with high-glucose-exposed 
ad-MVF (Fig. 6a,b). These scaffolds also exhibited 
a significantly higher microvessel density in their 
border zones when compared to controls (Fig. 6c,f,i). 
In contrast, the microvessel density in the centre of 
the implants was comparable in both groups (Fig. 
6i). Moreover, they presented with a comparably 
high fraction of > 80 % GFP+ microvessels in their 
border and centre zones (Fig. 6d,e,g,h,j). Finally, 
the analysis of sirius-red-stained sections revealed 
a tendency towards a higher total collagen ratio in 
scaffolds seeded with high-glucose-exposed ad-MVF, 
indicating an improved tissue incorporation when 
compared to controls (Fig. 6k-n).
Discussion
The present study demonstrated that exposure of 
cultivated ad-MVF to high glucose concentrations 
promoted their proliferation and in vivo network 
formation. Hence, this novel approach may improve 
the outcome of future therapeutic interventions 
using ad-MVF as vascularisation units. The short-
term cultivation of ad-MVF may be particularly 
recommended in clinical cases in which freshly 
isolated ad-MVF cannot be directly retransferred 
into patients due to prolonged or multi-step surgical 
procedures. For this purpose, ad-MVF should be 
cultivated at 4 °C in UW solution to prevent their 
agglomeration and to ensure xeno-free culture 
conditions according to good manufacturing practices 
(Laschke et al., 2019b). Those novel results indicated 
that these conditions can be further optimised by 
adding 30 mM glucose to the UW solution, which 
is, in contrast to the use of recombinant growth 
factors, a cost-effective and, from a regulatory point 
of view, harmless approach to effectively increase the 
angiogenic activity of ad-MVF.
 The pro-angiogenic effect of high glucose is not a 
novel finding but well known from studies focusing 
on the mechanisms underlying diabetes-induced 
aberrant angiogenesis (Betts-Obregon et al., 2016; 
Fernando et al., 2018; Qiu et al., 2018; Shi et al., 2019). 
Such studies are often performed with endothelial 
cell monocultures that are exposed to different 
glucose concentrations. In contrast, in the present 
study, ad-MVF were used with an intact vessel 
morphology and physiological cellular composition, 
including microvessel-attached pericytes. Hence, 
these fully functional vessel segments may provide 
more realistic conditions to study the effects of high 
Fig. 5. Vascular maturation and remodelling of ad-
MVF. (a,b) Intravital fluorescence microscopy (blue-
light epi-illumination with contrast enhancement 
by 5 % FITC-labelled dextran 150,000 injected 
intravenous) of individual microvessels within ad-
MVF-seeded collagen-glycosaminoglycan scaffolds 
on day 14 after implantation into the dorsal skinfold 
chamber of C57BL/6 mice. ad-MVF were cultivated 
for 24 h in 4 °C UW solution supplemented with 
(a) vehicle or (b) high glucose. Scale bars: 20 µm. 
(c) Diameter (µm), (d) centreline RBC velocity 
(µm/s) and (e) wall shear rate (s−1) of individual 
microvessels within ad-MVF-seeded collagen-
glycosaminoglycan scaffolds 3, 6, 10 and 14 d after 
implantation into dorsal skinfold chambers, as 
assessed by intravital fluorescence microscopy. ad-
MVF were cultivated for 24 h in 4 °C UW solution 
supplemented with vehicle (white circles, n = 9) 
or high glucose (black circles, n = 9). Mean ± SEM; 
*p < 0.05 vs. vehicle. 
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Fig. 6. Final vascularisation and incorporation of ad-MVF-seeded scaffolds. (a,b) HE-stained sections of 
ad-MVF-seeded collagen-glycosaminoglycan scaffolds (borders marked by broken line) on day 14 after 
implantation into the dorsal skinfold chamber of C57BL/6 mice. ad-MVF were cultivated for 24 h in 4 °C UW 
solution supplemented with (a) vehicle or (b) high glucose. Scale bars: 350 µm. (c-h) Immunohistochemically 
stained microvessels in the border of ad-MVF-seeded collagen-glycosaminoglycan scaffolds on day 14 after 
implantation into the dorsal skinfold chambers of C57BL/6 mice. ad-MVF were cultivated for 24 h in 4 °C UW 
solution supplemented with (c-e) vehicle or (f-h) high glucose. (c-h) Staining was performed with Hoechst 
33342 to identify cell nuclei (blue), (c,f) an antibody against CD31 for the detection of endothelial cells (red) 
and (d,g) an antibody against GFP (green). (e,h) Merge of c,d and f,g. Arrows = CD31+/GFP+ microvessels; 
arrowheads = CD31+/GFP− microvessels. Scale bars: 25 µm. (i) Microvessel density (mm−2) and (j) GFP+ 
microvessels percentage in the centre and border zones of ad-MVF-seeded collagen-glycosaminoglycan 
scaffolds 14 d after implantation into the dorsal skinfold chamber, as assessed by immunohistochemical 
analysis. ad-MVF were cultivated for 24 h in 4 °C UW solution supplemented with vehicle (white bars, n = 9) 
or high glucose (black bars, n = 9). Mean ± SEM; * p < 0.05 vs. vehicle. Sirius-red-stained sections of (k) normal 
skin as well as (l,m) ad-MVF-seeded collagen-glycosaminoglycan scaffolds on day 14 after implantation 
into the dorsal skinfold chamber of C57BL/6 mice. ad-MVF were cultivated for 24 h in 4 °C UW solution 
supplemented with (l) vehicle or (m) high glucose. Scale bars: 30 µm. (n) Total collagen ratio in ad-MVF-
seeded collagen-glycosaminoglycan scaffolds 14 d after implantation into the dorsal skinfold chamber, as 
assessed by histological analysis. ad-MVF were cultivated for 24 h in 4 °C UW solution supplemented with 
vehicle (white bar, n = 9) or high glucose (black bar, n = 9). Mean ± SEM.
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glucose on microvessels and, thus, may also be 
recommended as explants for future in vitro studies 
in diabetes research. In line with this view, not only 
was the stimulating effect of glucose on endothelial 
cell proliferation (Fernando et al., 2018; Qiu et al., 
2018) confirmed, but also larger numbers of Ki67+ 
proliferating perivascular cells were detected in 
high-glucose-exposed ad-MVF when compared 
to vehicle-exposed controls. This indicated that 
vessel-wall-stabilising cells crucially contribute to 
diabetes-related microvasculopathy. Moreover, 
scanning electron microscopy analyses revealed that 
high-glucose-exposed ad-MVF exhibited multiple 
nanopores. On the one hand, these nanopores may 
result from glucose-induced cellular damage and 
beginning necrosis. On the other hand, they may be 
interpreted as an early sign of angiogenesis, which 
is typically associated with an increased vascular 
permeability, degradation of the basal lamina and 
disintegration of the vessel wall (Díaz-Flores et al., 
2017). When getting larger, these nanopores may 
also represent the morphological correlate to the 
haemorrhages that are clinically observed in diabetic 
retinopathy (Murugesan et al., 2015). Diabetes-induced 
microvascular abnormalities additionally include 
microaneurysms, exudates and microthromboses 
(Murugesan et al., 2015), indicating an impaired vessel 
functionality. Hence, it is reasonable to assume that a 
longer exposure to supraphysiological glucose levels, 
as they occur in diabetic patients, would rather reduce 
the regenerative potential of ad-MVF. However, this 
issue needs further clarification.
 A major prerequisite for the reassembly of ad-
MVF into new microvascular networks is their 
growth towards each other by the process of 
sprouting angiogenesis (Nunes et al., 2010). This 
process is initiated and driven by the complex 
interplay of multiple pro- and anti-angiogenic 
factors (Weis and Cheresh, 2011). To study the effect 
of high glucose on the expression of these factors, 
a proteome profiler mouse angiogenesis array was 
performed. Of interest, an altered protein expression 
pattern was found in high-glucose-exposed ad-
MVF, with endoglin, IL-1β and MCP-1 as the most 
upregulated factors when compared to vehicle-
exposed controls. Endoglin is a glycoprotein, which is 
typically upregulated in angiogenic endothelial cells, 
where it promotes proliferation and migration via 
transforming growth factor (TGF)-β/activin receptor-
like kinase (ALK)1/Smad1/5/8 signalling (Kasprzak 
and Adamek, 2018). IL-1β and MCP-1 are primarily 
known as pro-inflammatory cytokines, which recruit 
different immune cell types to sites of inflammation 
(Bianconi et al., 2018; Fenini et al., 2017). However, 
several studies have shown that they also exert pro-
angiogenic effects, indicating a close link between 
inflammation and angiogenesis (Hayashi et al., 2015; 
Mohr et al., 2017; Sun et al., 2016). Of note, this link 
is a typical feature of diabetes-related angiogenic 
pathologies too (Capitão and Soares, 2016). In 
addition, a strong down-regulation of pro-angiogenic 
factors, such as MMP-8, was detected that did not, 
however, shift the analysed ad-MVF towards an anti-
angiogenic phenotype. This may be explained by the 
fact that anti-angiogenic factors, such as TIMP-1, the 
counterpart of MMP-8, were also down-regulated in 
high-glucose-exposed ad-MVF.
 To assess their in vivo vascularisation capacity, 
vehicle- and high-glucose-exposed ad-MVF from 
GFP+ donor mice were analysed in dorsal skinfold 
chambers of GFP− recipient animals. By means of this 
GFP+/GFP− cross-over design, it was demonstrated 
that in both groups most of the GFP+ ad-MVF survived 
and mainly contributed to the final vascularisation 
of the seeded scaffolds at day 14 after implantation. 
However, this vascularisation was markedly 
improved in the group of high-glucose-treated ad-
MVF, as indicated by a significantly higher functional 
microvessel density when compared to controls. This 
finding was in line with the pro-angiogenic effects 
of high glucose observed in the in vitro analyses. 
Besides these effects, other mechanisms may have 
further contributed to this positive outcome. In 
fact, Yoon et al. (2014) reported that high glucose 
conditions induce Jagged1 and suppress Notch1 
expression in endothelial cells. These conditions 
promote the specification of endothelial cells to 
the tip cell phenotype, which is highly motile and 
guides endothelial sprouts towards growth factor 
stimuli (Chen et al., 2019). Accordingly, Yoon et al. 
(2014) additionally detected an increased angiogenic 
sprouting and branching of glucose-exposed 
endothelial cell/smooth muscle cell spheroids, 
resulting in a higher density of newly developing 
microvascular networks. Furthermore, high shear 
forces, as assessed in the present study in individual 
microvessels of the high glucose group, stimulate 
vascular sprouting (Galie et al., 2014).
Conclusion
Exposure of cultivated ad-MVF to high glucose 
concentrations resulted to be a promising approach 
to improve their in vivo vascularisation capacity. 
A rapid and sufficient vascularisation is of pivotal 
importance for the incorporation of biomaterials 
into the surrounding host tissue (Reichel et al., 2015). 
In the present study, this was reflected by a denser 
granulation tissue and a higher collagen content 
within the scaffolds seeded with high-glucose-
exposed ad-MVF when compared to controls. 
In addition, survival and long-term function of 
implanted tissue constructs was crucially determined 
by an adequate blood supply (Laschke et al., 2006). 
Hence, high-glucose-exposed ad-MVF may serve as 
versatile vascularisation units to use in a wide range 
of future applications in the fields of implant research, 
tissue engineering and regenerative medicine.
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Discussion with Reviewers
Daniel Schmauss : How did you choose the 
glucose concentration used? Could higher glucose 
concentrations have an even more pronounced effect?
Authors: The glucose concentration was chosen 
based on previous in vitro studies focusing on the 
angiogenic effects of glucose on endothelial cells 
(Betts-Obregon et al., 2016; Fernando et al., 2018; Qiu 
et al., 2018). In these studies, a concentration of 30 mM 
glucose is typically used to mimic hyperglycaemic 
conditions, as they occur in diabetic patients.
Daniel Schmauss: Do you think the nanopores in 
the vessel wall, described in the high-glucose group, 
might have a negative impact on the performance of 
the used ad-MVF if they would get larger? Or is this 
improbable given the short-term exposure to high 
glucose concentrations?
Authors: The observed nanopores may be interpreted 
in different ways. On the one hand, they may result 
from glucose-induced cellular damage and beginning 
necrosis. In this case, they would probably have a 
negative impact on the in vivo performance of the 
ad-MVF. On the other hand, they may be interpreted 
as an early sign of angiogenesis, which is typically 
associated with an increased vascular permeability, 
degradation of the basal lamina and disintegration 
of the vessel wall (Díaz-Flores et al., 2017). If this 
holds true, the nanopores would have a positive 
impact when getting larger during glucose exposure, 
resulting in an accelerated in vivo reassembly of 
individual ad-MVF into new microvascular networks.
Heiko Sorg: Have you tested systemic glucose 
administration?
Authors: No, in the present study, the systemic 
treatment of mice with high glucose concentrations 
was deliberately omitted. In fact, the aim was to 
test a new approach for improving the in vivo 
vascularisation capacity of ad-MVF without affecting 
the physiological health status of the recipients. In 
clinical practice, such an approach would be much 
more attractive, because potential side effects of a 
systemic treatment could be avoided. Nonetheless, 
we feel that the reviewer addresses the interesting 
question of how ad-MVF would perform when 
applied in diabetic patients. Since the prevalence of 
diabetes is continuously increasing, being particularly 
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high in older patients, who may also represent a main 
target group for future tissue engineering therapies, 
this relevant issue should be clarified in further 
experimental studies.
Heiko Sorg: From a clinical point of view, might 
liposuction be also sufficient to gain significant 
amounts of adMVF?
Authors: The isolation of ad-MVF from human 
liposuctioned fat is the desirable method for the 
future application of this concept in clinical practice. 
Currently, protocols are being developed to promote 
exactly this approach and, based on preliminary 
results, it seems possible to gain sufficient amounts 
of ad-MVF from this fat source.
Heiko Sorg: What would you presume would 
happen if exposing adMVF for more than 24 h to high 
glucose concentrations (< 72 h)? Might the shown 
effects be decreased?
Authors: We do not recommend exposing ad-MVF in 
vitro for more than 24 h to high glucose concentrations. 
In fact, ad-MVF lose their physiological vessel 
morphology when cultivated longer. Accordingly, 
they also exhibit an impaired in vivo vascularisation 
capacity (Laschke et al., 2015, additional reference). 
For these reasons, it is possible that the shown effects 
would indeed be decreased.
Heiko Sorg: The increase in collagen might also lead 
to fibrosis and scar formation. Can you comment on 
this?
Authors: Indeed, in the long run, the increased 
collagen formation may contribute to fibrosis and 
scarring. Because the present study assessed the 
incorporation of the scaffolds only in an early phase, 
i.e. 14 d after implantation, it is not possible to make a 
valid statement about the long-term performance of 
the implants. However, an early collagen formation 
was observed also within the pores of ad-MVF-
seeded scaffolds and not only at their interface with 
the surrounding host tissue. Hence, this pattern rather 
indicated an improved tissue ingrowth and implant 
incorporation, whereas a sole collagen formation 
around the implants would rather be a sign for 
scarring and scaffold fibrotic encapsulation over time.
Heiko Sorg: How do you explain the nearly explosive 
increase in perfused ROIs in Fig. 4 from day 3 nearly 
nothing to about 70-80 %?
Authors: This vascularisation pattern is typical for 
ad-MVF-seeded scaffolds. Due to their preserved 
vessel morphology, they rapidly reassemble in 
vivo into new microvascular networks. As soon as 
these networks also develop interconnections with 
the vessels of the surrounding host tissue, which 
typically occurs 3-6 d after implantation, they are 
completely blood-perfused within a short time. 
In contrast, scaffold vascularisation by angiogenic 
ingrowth of newly developing microvessels from the 
host microvasculature would be characterised by a 
slower but more uniform increase in perfused ROIs 
over time (Laschke et al., 2010, additional reference).
Additional Reference
 Laschke MW, Strohe A, Menger MD, Alini M, 
Eglin D (2010) In vitro and in vivo evaluation of a 
novel nanosize hydroxyapatite particles/poly(ester-
urethane) composite scaffold for bone tissue 
engineering. Acta Biomater 6: 2020-2027.
. Laschke MW, Kleer S, Scheuer C, Eglin D, Alini M, 
Menger MD (2015) Pre-cultivation of adipose tissue-
derived microvascular fragments in porous scaffolds 
does not improve their in vivo vascularisation 
potential. Eur Cell Mater 29: 190-200.
Editor’s note: The Scientific Editor responsible for 
this paper was Juerg Gasser.
